Stay updated on Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial page.

Latest updates to the Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe record history now includes a new revision entry 'v3.6.4' and removes the previous 'v3.6.3' entry. This indicates an update to the page's versioning metadata rather than changes to trial data or study details.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision entry v3.6.3 is added to the study record history, and the previous revision v3.6.2 is removed, reflecting an update to the revision history.SummaryDifference0.1%

- Check42 days agoChange DetectedThe history now includes the latest site revision label, v3.6.2, replacing the prior v3.6.0. This reflects an internal deployment update and does not affect trial data or content.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry v3.6.0 was added to the study record, along with a note that the study is no longer looking for participants. The previous revision entry v3.5.5 has been removed from the history.SummaryDifference0.6%

- Check63 days agoChange DetectedThe history shows a new site revision (v3.5.5) replacing the previous revision, indicating a software release or UI update rather than changes to the study information.SummaryDifference0.1%

- Check85 days agoChange DetectedRecord History now includes a new version entry labeled Revision: v3.5.4. The previous entry Revision: v3.5.3 has been removed, reflecting an administrative update to the page's version history.SummaryDifference0.1%

Stay in the know with updates to Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dabrafenib, Trametinib, Spartalizumab in Melanoma Clinical Trial page.